Gilead Sciences Inc

NASDAQ: GILD
$89.88
+$0.74 (+0.8%)
Closing Price on January 10, 2025

GILD Articles

The March 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The February 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data have been compared with the previous report, and short interest in...
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in...
It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for Intercept Pharmaceuticals.
The top analyst upgrades, downgrades and initiations seen on Tuesday included BHP, Cisco Systems, Crown Castle, Gilead Sciences, Goldcorp, Take-Two Interactive Software, Varonis Systems and Whiting...
Gilead Sciences is living up to our theory that Big Biotech is now effectively the same as Big Pharma.
24/7 Wall St. has reviewed Disney, General Motors, Twitter and some of the other key stocks reporting earnings this coming week.
There is great opportunity in healthcare. There is also quite a lot of risk. Politicians and consumers alike want lower drug prices. Patients want the best of the best options for devices,...
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Gilead shares made a slight gain early on Monday after the firm announced that there would be a big change at the top, in terms of its senior management. Not to mention, this executive is coming from...
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.